# Studying Topiramate for Re-Activating the HIV-1 Reservoir

> **NCT06282783** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Erasmus Medical Center** · enrollment: 12 (estimated)

## Conditions studied

- HIV-1-infection
- Hiv
- HIV Infections
- HIV I Infection

## Interventions

- **DRUG:** Topiramate

## Key facts

- **NCT ID:** NCT06282783
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-09
- **Primary completion:** 2025-04
- **Final completion:** 2025-08
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06282783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06282783, "Studying Topiramate for Re-Activating the HIV-1 Reservoir". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06282783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*